Autogenous blood injection (ABI) for the treatment of recurrent dislocation of temporomandibular joint (TMJ) – a case report

by March 10, 2021
  • Version
  • Download 0
  • File Size 164 KB
  • File Count 1
  • Create Date March 10, 2021
  • Last Updated March 10, 2021

Autogenous blood injection (ABI) for the treatment of recurrent dislocation of temporomandibular joint (TMJ) – a case report

CS Seng, SAJS Zainal, AF Bustaman: Autogenous blood injection (ABI) for the treatment of recurrent dislocation of temporomandibular joint (TMJ) – a case report. Mal. J. Oral Maxillofac. Surg. 2014; 12: 18–20.

Abstract: Recurrent temporomandibular joint (TMJ) dislocation can be treated non- surgically, surgically or in a combination of both approaches. Autogenous blood injection (ABI) into TMJ cavity and pericapsular tissue has been advocated by many authorities to be a safe and effective treatment modality. Here, we would like to share our experience on the management of recurrent TMJ dislocation in a 29-year-old air force serviceman by employing ABI. The post-operative swelling was minimal and persisted for only 3 days. At 2 months follow up, the recovery was uneventful with significant improvement of his TMJ dislocation.